Status:
COMPLETED
A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering
Lead Sponsor:
Bayer
Conditions:
Erythema
Skin Recovery
Eligibility:
FEMALE
30-60 years
Phase:
PHASE4
Brief Summary
In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery and reduction of skin redness after a dermatological procedure (non-ablative laser) on the ...
Detailed Description
The primary objective is to evaluate the efficacy of the test product to aid skin recovery and reduction of erythema after non-ablative lasering on the face. Secondary objectives comprise clinical ef...
Eligibility Criteria
Inclusion
- Phototypes I or II according to the Fitzpatrick scale
- Participants willing to perform the dermatological procedure (non-ablative laser) on the face for treatment of fine wrinkles, scars and open pores, rosacea, poikiloderma, and melasma
- Normal eye examination
Exclusion
- Cutaneous pathologies and/or injuries as psoriasis, sensible skin, cancer of the skin, rosacea, atopic dermatitis or other medical criteria to be considered at the moment of the evaluation;
- Hyperpigmentation in the test area that intervenes with the evaluation of possible reactions
- Active cutaneous pathologies and/or injuries (local and/or disseminated) in the evaluation area
- Aesthetic or dermatological treatment in the area of evaluation up to 04 weeks before the selection
Key Trial Info
Start Date :
January 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2019
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03853538
Start Date
January 28 2019
End Date
March 6 2019
Last Update
March 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medcin Instituto da Pele
São Paulo, Brazil, 06023-070